Side Effects of mesalamine rectal: A Synthesis of Findings from 29 Studies
- Home
- Side Effects of mesalamine rectal
This analysis is based on research papers included in PubMed, but medical research is constantly evolving and may not fully reflect the latest findings. There may also be biases towards certain research areas.
This information is not medical advice and is not a substitute for diagnosis or treatment by a physician. If you have concerns about "Side Effects of mesalamine rectal: A Synthesis of Findings from 29 Studies", please consult your doctor.
For NLM copyright information, please see Link to NLM Copyright Page
PubMed data is obtained via Hugging Face Datasets: Link to DatasetPlease check the disclaimer.
Major findings of the study
Mesalamine is a drug that has been used for many years to treat ulcerative colitis. It is the active ingredient in sulfasalazine and is known to have fewer side effects than sulfasalazine. 13 Mesalamine has been shown to improve symptoms of ulcerative colitis and maintain remission. 8 Mesalamine is available in various formulations, such as oral and rectal. 8
Reasons for side effects
Side effects of mesalamine may occur when mesalamine is metabolized in the intestinal tract. 24 Mesalamine can bind to iron to generate reactive oxygen species, which can damage cells. 24 Also, mesalamine can be broken down by intestinal bacteria, which can produce toxic metabolites. 13 These metabolites may be the cause of side effects.
Common side effects
Gastrointestinal
Gastrointestinal side effects can occur when using mesalamine. 12 The most common side effects are diarrhea, abdominal pain, nausea, and vomiting. 12 Maldigestion, anorexia, and abdominal distention can also occur. 12 When using mesalamine rectal, local side effects such as anal irritation or pain may occur. 10 Mesalamine can bind to iron to generate reactive oxygen species, which can damage cells. 24 Mesalamine can be broken down by intestinal bacteria, which can produce toxic metabolites. 13 These metabolites may be the cause of gastrointestinal side effects.
Liver
Mesalamine may affect the liver. 24 Mesalamine can bind to iron to generate reactive oxygen species, which can damage liver cells. 24 Mesalamine can also be metabolized in the liver, leading to liver dysfunction. 24
Kidney
Mesalamine may affect the kidney. 24 Mesalamine can bind to iron to generate reactive oxygen species, which can damage kidney cells. 24 Mesalamine can also be metabolized in the kidney, leading to kidney dysfunction. 24
Others
Side effects such as headache, dizziness, rash, and itching can occur when using mesalamine. 13 Mesalamine may also cause allergic reactions. 13
Countermeasures for side effects
Gastrointestinal
Gastrointestinal side effects can occur when using mesalamine. If you are concerned about side effects, consult your doctor. Side effects may be reduced by dietary changes or medication. Mesalamine is more likely to cause gastrointestinal side effects when taken on an empty stomach. It should be taken after meals or between meals. Also, drinking plenty of water can reduce side effects. Drink water or tea frequently.
Liver
Mesalamine may affect the liver. If you are concerned about side effects, consult your doctor. Have your liver health checked regularly.
Kidney
Mesalamine may affect the kidney. If you are concerned about side effects, consult your doctor. Have your kidney health checked regularly.
Others
Side effects such as headache, dizziness, rash, and itching can occur when using mesalamine. If you are concerned about side effects, consult your doctor. Mesalamine may also cause allergic reactions. If you experience an allergic reaction, consult your doctor immediately.
Comparison between studies
Commonalities
Many studies have shown that mesalamine is effective in treating ulcerative colitis. 19 Mesalamine has been shown to improve symptoms of ulcerative colitis and maintain remission. 8 Mesalamine is known to have fewer side effects than sulfasalazine. 13
Differences
The efficacy and side effects of mesalamine may vary depending on the type and method of administration. 8 Various formulations of mesalamine have been developed, and the efficacy and side effects differ depending on the formulation. 6
Precautions for applying to real life
Mesalamine is used by many patients as a treatment for ulcerative colitis. 13 Mesalamine is generally a safe drug, but there is a possibility of side effects. 13 It is important to follow your doctor's instructions and be aware of side effects when using mesalamine. Various formulations of mesalamine have been developed. 6 The efficacy and side effects differ depending on the formulation, so consult your doctor and choose the formulation that is right for you.
Limitations of current research
Research on the side effects of mesalamine is still insufficient. Various formulations of mesalamine have been developed, and the efficacy and side effects differ depending on the formulation. 6 Further research is needed on the long-term safety and efficacy of mesalamine.
Future research directions
Further research is needed to better understand the side effects of mesalamine. The development of new treatments and formulations to reduce the side effects of mesalamine is also needed.
Conclusion
Mesalamine is used by many patients as a treatment for ulcerative colitis. Mesalamine is generally a safe drug, but there is a possibility of side effects. It is important to follow your doctor's instructions and be aware of side effects when using mesalamine. Various formulations of mesalamine have been developed. Consult your doctor and choose the formulation that is right for you.
Benefit Keywords
Risk Keywords
Article Type
Author: MahamiSolmaz, SalehiMajid, MehrabiMohsen, VahediHamid, HassaniMaryam Sadat, BitarafFatemeh Sadat, OmriAbdelwahab
Language : English
Author: ZhangYujie, ChenDi, WangFang, LiXiaowei, XueXianmin, JiangMingzuo, XuBing, ChuYi, WangWeijie, WuKaichun, MaoRen, ShenJun, YangShaoqi, LiangJie
Language : English
Author: ArgyriouKonstantinos, SamuelSunil, MoranGordon W
Language : English
Author: KruisWolfgang, NeshtaViacheslav, PesegovaMarina, AlekseevaOlga, AndreevPavel, DatsenkoOleksii, LevchenkoOlena, AbdulkhakovSayar, LozynskyyYuriy, MostovoyYuriy, SolovievKonstantin, DorofeyevAndrey E, ViethMichael, StiessMichael, GreinwaldRoland, MohrbacherRalf, SiegmundBritta
Language : English
Author: SeiboldF, FournierN, BeglingerC, MottetC, PittetV, RoglerG,
Language : English
Author: KlotzU
Language : English
Author: RoglerG, BeglingerC, MottetC, SeiboldF, GrossV
Language : German
Author: CottoneMario, RennaSara, ModestoIrene, OrlandoAmbrogio
Language : English
Author: SeoEun Hee, KimTae Oh, KimTae Gyoon, JooHee Rin, ParkJongha, ParkSeung Ha, YangSung Yeon, MoonYoung Soo, ParkMin Jae, RyuDong Yup, SongGeun Am
Language : English
Author: LoewBurr J, SiegelCorey A
Language : English
Author: TursiAntonio, BrandimarteGiovanni, PapaAlfredo, GiglioAndrea, EliseiWalter, GiorgettiGian Marco, FortiGiacomo, MoriniSergio, HassanCesare, PistoiaMaria Antonietta, ModeoMaria Ester, Rodino'Stefano, D'AmicoTeresa, SebkovaLadislava, Sacca'Natale, Di GiulioEmilio, LuzzaFrancesco, ImeneoMaria, LarussaTiziana, Di RosaSalvatore, AnneseVito, DaneseSilvio, GasbarriniAntonio
Language : English
Language : English
Author: CohenHillel D, DasKiron M
Language : English
Author: TokuiKenji, AsaiYoshitaka, ArakawaToshiharu, MatsumotoTakatoshi, NabeshimaToshitaka
Language : English
Author: MarteauP, FlorentC
Language : English
Author: RobinsonM
Language : English
Author: RobinsonM
Language : English
Author: GreenJ T, ThomasG A, RhodesJ, WilliamsG T, EvansB K, RussellM A, FeyerabendC, RhodesP, SandbornW J
Language : English
Author: MarshallJ K, IrvineE J
Language : English
Author: Bianchi PorroG, ArdizzoneS, PetrilloM, FasoliA, MolteniP, ImbesiV
Language : English
Author: AndreoliA, SpinellaS, LevensteinS, PranteraC
Language : English
Author: WinterT A, DaltonH R, MerrettM N, CampbellA, JewellD P
Language : English
Author: SchmassmannA, HalterF
Language : German
Prooxidant properties of 5-aminosalicylic acid. Possible mechanism for its adverse side effects.
Author: GrishamM B, WareK, MarshallS, YamadaT, SandhuI S
Language : English
Author: NgôY, RambaudJ C
Language : French
Author: MadsenJ R, LaursenL S, LauritsenK
Language : Danish
Author: D'ArienzoA, PanareseA, D'ArmientoF P, LanciaC, QuattroneP, GiannattasioF, BoscainoA, MazzaccaG
Language : English
Language : English
This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.